- Investing Ideas
- /
- Chinese Biotech Breakthroughs
Chinese Biotech Breakthroughs
Results
7
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
7 companies
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥24.5b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥92.70
7D
-6.9%
1Y
50.5%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥26.6b
A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.
688192
CN¥57.60
7D
-0.9%
1Y
44.0%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.5b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥26.35
7D
0.9%
1Y
49.3%
Changchun BCHT Biotechnology
Market Cap: CN¥7.8b
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
688276
CN¥18.86
7D
-1.7%
1Y
-20.3%
Chongqing Zhifei Biological Products
Market Cap: CN¥45.2b
Chongqing Zhifei Biological Products Co., Ltd.
300122
CN¥18.87
7D
-1.9%
1Y
-23.8%
Shenzhen Kangtai Biological Products
Market Cap: CN¥16.5b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥14.77
7D
-2.3%
1Y
-8.1%
Nanjing Vazyme Biotech
Market Cap: CN¥8.0b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥20.02
7D
0.6%
1Y
-8.4%